Saúde Pública/Medicina Humanitária
Choosing Wisely | Sete perguntas que médicos e residentes/pacientes deveriam fazer nos cuidados de longo prazo.
8 Out, 2021 | 11:48hVer listas completas de práticas de baixo valor: Choosing Wisely U.S. / Choosing Wisely UK / Choosing Wisely Australia E Choosing Wisely Canada
Recomendações da EMA sobre doses extras e de reforço das vacinas mRNA da BioNTech/Pfizer e da Moderna.
8 Out, 2021 | 11:26hComirnaty and Spikevax: EMA recommendations on extra doses and boosters – European Medicines Agency
Conteúdo relacionado: The difference between COVID-19 ‘third doses’ and ‘boosters’ – Emory News Center
Comentário no Twitter
EMA recommended additional doses and boosters for #Comirnaty and #Spikevax. https://t.co/qefPg2kMMO
In this context, see below what the difference between an additional dose and a #boosterdose is. pic.twitter.com/HeyOACbWXm
— EU Medicines Agency (@EMA_News) October 5, 2021
Estudo de coorte | Efeitos dos lockdowns ocorridos na pandemia de COVID-19 sobre as cirurgias oncológicas eletivas para 15 tipos de tumores em 61 países.
8 Out, 2021 | 11:25h
Comentário no Twitter (fio – clique para saber mais)
What were the unintended consequences of COVID lockdowns on cancer care?@CovidSurg study in @TheLancetOncol:
🔹Lockdowns independently associated with delayed treatment
🔹At median 5.3 months f/u, 1 in 7 pts had not had planned cancer surgery🆓https://t.co/UZe0euq5kg pic.twitter.com/4fPl6UEb9D
— Dmitri Nepogodiev (@dnepo) October 5, 2021
O que se sabe – e o que não se sabe – sobre a nova pílula da Merck para Covid-19.
8 Out, 2021 | 11:23hWhat we know — and don’t know — about Merck’s new Covid-19 pill – STAT
Conteúdos relacionados:
Merck’s Covid-19 pill is great news but may not be a game-changer.
Video | A Pill For COVID? A Doctor Explains Molnupiravir.
Opinião | Por que os americanos ainda – Ainda! – estão usando máscaras de tecido?
8 Out, 2021 | 11:21hWhy Are Americans Still—Still!—Wearing Cloth Masks? – The Atlantic
Conteúdos relacionados:
Evidence shows that, yes, masks prevent COVID-19 – and surgical masks are the way to go.
[Preprint] Largest study of masks yet details their importance in fighting Covid-19.
Comentário no Twitter
Any mask is better than no mask, especially indoors. But for those who are at higher risk of severe disease or around lots of unvaccinated people, consider upgrading to an N95 (or equivalent) mask, which are more protective. https://t.co/vhNPadTP8O
— Dr. Tom Frieden (@DrTomFrieden) October 5, 2021
Suplemento | Triunfos da vacinação.
8 Out, 2021 | 11:05hPágina principal: Triumphs of Vaccination – The Journal of Infectious Diseases
Hib Vaccines: Their Impact on Haemophilus influenzae Type b Disease
The Rotavirus Vaccine Story: From Discovery to the Eventual Control of Rotavirus Disease
Triumph of Pneumococcal Conjugate Vaccines: Overcoming a Common Foe
Rubella Eradication: Not Yet Accomplished, but Entirely Feasible
Live Attenuated Varicella Vaccine: Prevention of Varicella and of Zoster
Immunization Against Poliomyelitis and the Challenges to Worldwide Poliomyelitis Eradication
Influenza Vaccines: Successes and Continuing Challenges
Measles in the 21st Century: Progress Toward Achieving and Sustaining Elimination
Overview of the United States’ Immunization Program
The World of Immunization: Achievements, Challenges, and Strategic Vision for the Next Decade
No fim das contas, o sal faz bem? Evidências dizem que não.
8 Out, 2021 | 11:00hIs salt good for you after all? The evidence says no – The Conversation
Conteúdos relacionados:
Systematic Review: Altered dietary salt intake for people with chronic kidney disease.
New WHO benchmarks help countries reduce salt intake and save lives.
RCT: Reduced-sodium added-potassium salt substitute reduces blood pressure in hypertensive patients
Potassium Enriched Salt Substitution Could Prevent a Large Number of Cardiovascular Deaths
Meta-Analysis: Effect of Reduction in Dietary Sodium on Blood Pressure Levels
Estudo de coorte | Efetividade da vacina da Pfizer contra qualquer infecção caiu de 88% no 1º mês após a vacinação completa para 47% após 5 meses. A efetividade da vacina contra internações permaneceu alta: 87% em 1 mês e 88% depois de 5 meses da vacinação completa, sem declínio significativo.
5 Out, 2021 | 11:36hComentário: Expert reaction to study on Pfizer-BioNTech vaccine effectiveness up to 6 months – Science Media Centre
Comentário no Twitter
Study of 3.4 million people @aboutKP @TheLancet
Vaccine efficacy against infections:
– First month post: 88%
– 5 months post: 47%But vaccine efficacy against hospitalization (Figure):
– First month post: 87%
– 5 months post: 88 %https://t.co/1Gse0FKpoI pic.twitter.com/p9wyiaWGeg— Vincent Rajkumar (@VincentRK) October 4, 2021
Estudo de coorte | Miocardite aguda após vacina de mRNA contra COVID-19 em maiores de 18 anos é rara, e a maioria dos casos não é grave.
5 Out, 2021 | 11:34hEditorial: COVID-19 Messenger RNA Vaccination and Myocarditis—A Rare and Mostly Mild Adverse Effect
Comentário no Twitter
New report on very rare acute myocarditis after mRNA vaccination in age 18+
5.8 cases/million after 2nd dose, 0.8/million 1st dose, all cases fully resolved with conservative managementhttps://t.co/Mfh5ImiSpW @KPSCALnews @KPSCalResearch @JAMAInternalMed— Eric Topol (@EricTopol) October 4, 2021
Nova Zelândia reconhece que não conseguirá mais ficar completamente livre do coronavírus.
5 Out, 2021 | 11:29hNew Zealand acknowledges it can no longer completely get rid of the coronavirus – NPR
Ver também:
New Zealand admits it can no longer get rid of coronavirus – Associated Press
Battling Delta, New Zealand Abandons Its Zero-Covid Ambitions – The New York Times